Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-02-24 @ 10:55 AM
Study NCT ID:
NCT00511069
Status:
COMPLETED
Last Update Posted:
2008-11-24
First Post:
2007-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia
Sponsor:
University of Bologna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CML/033-26866138-CAN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Giovanni Martinelli
Old Organization:
Dipartimento di Ematologia "seragnoli"- Policlinico Sant'Orsola Bologna